博騰股份(300363.SZ)提示風險:公司滾動市盈率為103.05倍
格隆匯3月17日丨博騰股份(300363.SZ)發佈股票交易異常波動暨風險提示公告,經核實,公司控股股東、實際控制人的質押股份不存在平倉風險,控股股東及實際控制人不存在可能導致公司控制權發生變更的事項。
根據中國證監會發布的行業分類結果,公司所處行業為醫藥製造業。經查詢中證指數有限公司官網,截至2020年3月17日收盤,公司滾動市盈率為103.05倍,醫藥製造業的滾動市盈率為34.49倍。敬請廣大投資者注意二級市場交易風險,理性決策,審慎投資。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.